Abstract:Excessive inflammatory response and apoptosis play key roles in the pathogenic mechanisms of sepsis-induced acute lung injury (ALI); however, the molecular pathways linked to ALI pathogenesis remain unclear. Recently, microRNAs (miRNAs/miRs) have emerged as important regulators of inflammation and apoptosis in sepsis-induced ALI; however, the exact regulatory mechanisms of miRNAs remain poorly understood. In the present study, the gene microarray dataset GSE133733 obtained from the Gene Expression Omnibus database was analyzed and a total of 38 differentially regulated miRNAs were identified, including 17 upregulated miRNAs and 21 downregulated miRNAs, in mice with lipopolysaccharide (LPS)-induced ALI, in comparison to the normal control mice. miR-129 was found to be the most significant miRNA, among the identified miRNAs. The upregulation of miR-129 markedly alleviated LPS-induced lung injury, as indicated by the decrease in lung permeability in and the wet-to-dry lung weight ratio, as well as the improved survival rate of mice with ALI administered miR-129 mimic. Moreover, the upregulation of miR-129 reduced pulmonary inflammation and apoptosis in mice with ALI. Of note, transforming growth factor activated kinase-1 (TAK1), a well-known regulator of the nuclear factor-kappa B (NF-kappa B) pathway, was directly targeted by miR-129 in RAW 264.7 cells. More importantly, miR-129 upregulation impeded the LPS-induced activation of the TAK1/NF-kappa B signaling pathway, as illustrated by the suppression of the nuclear phosphorylated-p65, p-I kappa B-alpha and p-IKK beta expression levels. Collectively, the findings of the present study indicate that miR-129 protects mice against sepsis-induced ALI by suppressing pulmonary inflammation and apoptosis through the regulation of the TAK1/NF-kappa B signaling pathway. This introduces the basis for future research concerning the application of miR-129 and its targets for the treatment of ALI.

MiR-106a-5p targets PFKFB3 and improves sepsis through regulating macrophage pyroptosis and inflammatory response

MicroRNA‑129 Plays a Protective Role in Sepsis‑induced Acute Lung Injury Through the Suppression of Pulmonary Inflammation Via the Modulation of the TAK1/NF‑κB Pathway.

Deficiency of Myeloid Pfkfb3 Protects Mice From Lung Edema and Cardiac Dysfunction in LPS-Induced Endotoxemia

Methylation of miR‐19b‐3p promoter exacerbates inflammatory responses in sepsis‐induced ALI via targeting KLF7

MicroRNA-138 Aggravates Inflammatory Responses of Macrophages by Targeting SIRT1 and Regulating the NF-κB and AKT Pathways.

rTM reprograms macrophages via the HIF-1α/METTL3/PFKM axis to protect mice against sepsis

MiR-107-3p Knockdown Alleviates Endothelial Injury in Sepsis Via Kallikrein-Related Peptidase 5.

Inhibition of PI3K p110δ rebalanced Th17/Treg and reduced macrophages pyroptosis in LPS-induced sepsis

PFKFB3 Promotes Endotoxemia-Induced Myocardial Dysfunction Through Inflammatory Signaling and Apoptotic Induction

Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3

MiR‐146a‐5p accelerates sepsis through dendritic cell activation and glycolysis via targeting ATG7

MiR-342-5p Alleviates Inflammatory Responses in Sepsis-Induced AKI by Targeting PFN1

Role of PFKFB3-driven glycolysis in sepsis

Mir-212-3p Inhibits Lps-Induced Inflammatory Response Through Targeting Hmgb1 in Murine Macrophages

Macrophage-derived exosomal miRNA-141 triggers endothelial cell pyroptosis by targeting NLRP3 to accelerate sepsis progression

Ablation of Endothelial Pfkfb3 Protects Mice from Acute Lung Injury in LPS-induced Endotoxemia.

Inhibition of MicroRNA 195 Prevents Apoptosis and Multiple-Organ Injury in Mouse Models of Sepsis

Inhibition of PFKFB Preserves Intestinal Barrier Function in Sepsis by Inhibiting NLRP3/GSDMD

microRNA-590-3p regulates inflammation and organ dysfunction in sepsis mouse model via the Syap1-mediated TGF-β/Smad signaling pathway

Platelet Exosome-Derived miR-223-3p Regulates Pyroptosis in the Cell Model of Sepsis-Induced Acute Renal Injury by Targeting Mediates NLRP3

MCPIP1 Alleviated Lipopolysaccharide‐induced Liver Injury by Regulating SIRT1 Via Modulation of Microrna‐9